These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 17669370

  • 1. Allosteric effects of antagonists on signalling by the chemokine receptor CCR5.
    Haworth B, Lin H, Fidock M, Dorr P, Strange PG.
    Biochem Pharmacol; 2007 Sep 15; 74(6):891-7. PubMed ID: 17669370
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological characterization of the chemokine receptor, CCR5.
    Mueller A, Mahmoud NG, Goedecke MC, McKeating JA, Strange PG.
    Br J Pharmacol; 2002 Feb 15; 135(4):1033-43. PubMed ID: 11861332
    [Abstract] [Full Text] [Related]

  • 3. Analysis of second messenger pathways stimulated by different chemokines acting at the chemokine receptor CCR5.
    Leach K, Charlton SJ, Strange PG.
    Biochem Pharmacol; 2007 Sep 15; 74(6):881-90. PubMed ID: 17645873
    [Abstract] [Full Text] [Related]

  • 4. Diverse signalling by different chemokines through the chemokine receptor CCR5.
    Mueller A, Mahmoud NG, Strange PG.
    Biochem Pharmacol; 2006 Sep 14; 72(6):739-48. PubMed ID: 16844091
    [Abstract] [Full Text] [Related]

  • 5. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
    Andrews G, Jones C, Wreggett KA.
    Mol Pharmacol; 2008 Mar 14; 73(3):855-67. PubMed ID: 18042736
    [Abstract] [Full Text] [Related]

  • 6. CCR5 internalisation and signalling have different dependence on membrane lipid raft integrity.
    Cardaba CM, Kerr JS, Mueller A.
    Cell Signal; 2008 Sep 14; 20(9):1687-94. PubMed ID: 18573334
    [Abstract] [Full Text] [Related]

  • 7. pH-independent endocytic cycling of the chemokine receptor CCR5.
    Signoret N, Christophe T, Oppermann M, Marsh M.
    Traffic; 2004 Jul 14; 5(7):529-43. PubMed ID: 15180829
    [Abstract] [Full Text] [Related]

  • 8. The relative activity of "function sparing" HIV-1 entry inhibitors on viral entry and CCR5 internalization: is allosteric functional selectivity a valuable therapeutic property?
    Muniz-Medina VM, Jones S, Maglich JM, Galardi C, Hollingsworth RE, Kazmierski WM, Ferris RG, Edelstein MP, Chiswell KE, Kenakin TP.
    Mol Pharmacol; 2009 Mar 14; 75(3):490-501. PubMed ID: 19064629
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Chemokine receptor CCR5 functionally couples to inhibitory G proteins and undergoes desensitization.
    Zhao J, Ma L, Wu YL, Wang P, Hu W, Pei G.
    J Cell Biochem; 1998 Oct 01; 71(1):36-45. PubMed ID: 9736452
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Selection of CC chemokine receptor 5-binding peptide from a phage display peptide library.
    Wang FY, Zhang TY, Luo JX, He GA, Gu QL, Xiao F.
    Biosci Biotechnol Biochem; 2006 Sep 01; 70(9):2035-41. PubMed ID: 16960395
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of inverse agonist action at D2 dopamine receptors.
    Roberts DJ, Strange PG.
    Br J Pharmacol; 2005 May 01; 145(1):34-42. PubMed ID: 15735658
    [Abstract] [Full Text] [Related]

  • 16. The activation mechanism of chemokine receptor CCR5 involves common structural changes but a different network of interhelical interactions relative to rhodopsin.
    Springael JY, de Poorter C, Deupi X, Van Durme J, Pardo L, Parmentier M.
    Cell Signal; 2007 Jul 01; 19(7):1446-56. PubMed ID: 17320349
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor.
    Watson C, Jenkinson S, Kazmierski W, Kenakin T.
    Mol Pharmacol; 2005 Apr 01; 67(4):1268-82. PubMed ID: 15644495
    [Abstract] [Full Text] [Related]

  • 20. Segment-dependent activation of muscarinic acetylcholine receptor-mediated [35S]Guanosine-5'-O-(gamma-thiotriphosphate) binding in airway tissue membranes.
    Hajek P, Ungemach FR, Abraham G.
    Pharmacology; 2009 Apr 01; 83(4):247-58. PubMed ID: 19295255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.